Methods Clinical Development News Today

•   Preliminary results of NATHALI-01 and updated results of BALLI-01 Phase I clinical studies presented at the American Society of Hematology 65th Annual Meeting •   Execution of strategic...

Food allergies, triggered by specific allergens, can lead to severe reactions like anaphylaxis. However, innovative treatments such as immunotherapy are revolutionizing allergy management.

The FDA approved delandistrogene moxeparvovec-rokl (Elevidys, Sarepta Therapeutics) in June to treat Duchenne muscular dystrophy in ambulatory pediatric patients aged 4 through 5 who have a confirmed DMD gene mutation.

•  Strategic Collaboration and Investment Agreements signed with AstraZenecaUpdated results of the Phase I BALLI-01 Trial evaluating UCART22 in r/...

October 24, 2023 Molecular Therapy: Methods & Clinical Development - Clinical Holds Manuscript Download ...

NEW YORK, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell

Avantor, Inc. announced the creation of a new Scientific Advisory Board, which will provide strategic guidance and consult on the Companys mid- to long-term research and development efforts to...

/PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services for customers in the life sciences and...

Microbiology experts Tim Sandle, Tony Cundell and Miriam Guest reflect on key developments in pharmaceutical microbiology during 2022.

Scientists from the Salk Institute for Biological Studies in La Jolla and the University of Sheffield in England co-led a study that shows promise for the development of gene therapies to repair hearing loss.